Franklin Genomic Advancements ETF CBOE - exBATS: HELX
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
Name | Franklin Genomic Advancements ETF |
Ticker | HELX |
Exchange | CBOE - exBATS |
Category | Health Care |
Sub Category | Biotech |
Price | 50.04 |
52W Low/High | 19.17 / 50.60 |
AUM | - |
1Y Total Return |
108.84%
Strong |
1Y Volatility |
35.87%
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
Details
Ticker | HELX |
Name | Franklin Genomic Advancements ETF |
ISIN | |
CUSIP | |
Exchange | CBOE - exBATS |
Category | Health Care |
Sub Category | Biotech |
Country | USA |
Currency | U.S. Dollar |
Benchmark | - |
Share as of 1/15/21
Close Price | 50.04 |
52W Low/High | 19.17 / 50.60 |
1Y Total Return |
108.84%
Strong |
1Y Volatility |
35.87%
Average Risk |
Beta | 0.01 |
12M Dividends | - |
Last Dividend Date | - |
Dist. Frequency | - |
Dividend Yield | - |
Data as of 1/19/21
AUM | - |
Discount/Premium | - |
NAV | - |
Shares Outstanding | - |
Volume 20D Avg | - |
Nbr of Holdings | - |
ETF Global Risk Rank | - |
Net Expense | - |
Options Available | - |
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available